Literature DB >> 24486362

Comparison of antibody and cell-mediated immune responses of foals and adult horses after vaccination with live Mycobacterium bovis BCG.

Tracy L Sturgill1, Steeve Giguère2, Londa J Berghaus1, David J Hurley3, Mary K Hondalus4.   

Abstract

BACKGROUND: Equine neonates have reduced humoral and cell-mediated immune responses compared to adult horses after administration of killed vaccines. As a basis for this study, we hypothesized that newborn foals can mount strong immune responses after vaccination with live Mycobacterium bovis BCG.
METHODS: Healthy 4-day-old foals (n=7), 4-month-old foals (n=7) and adult horses (n=6) were vaccinated once with live M. bovis BCG. Age-matched animals (n=5 per group) were used as unvaccinated controls. Relative vaccine-specific immunoglobulin concentrations and whole blood mRNA expression of IFN-γ, IL-4, and IL-10 were measured prior to and 2, 4, 6, and 8 weeks after vaccination. Eight weeks after vaccination, delayed type hypersensitivity (DTH) responses were assessed by measuring the increase in double skin thickness after intradermal injection of purified protein derivative.
RESULTS: Both groups of foals and adult horses responded with a significant increase in vaccine-specific total IgG, IgGa, IgGc, IgG(T), and IgM concentrations. In contrast, only adult horses mounted significant IgGb responses. Vaccine-specific concentrations of total IgG and IgGa were significantly higher in adult horses than in 4-day-old foals whereas IgGc responses were significantly higher in 4-day-old foals than in the other two age groups. Adult horses had significantly higher basal IFN-γ and IL-4 mRNA expression than both groups of foals but vaccination with M. bovis BCG did not significantly increase expression of these cytokines, regardless of age group. Immunized horses had significantly higher DTH responses than age-matched unvaccinated controls. DTH responses were significantly greater in both groups of vaccinated foals than in vaccinated adult horses.
CONCLUSION: Despite a naïve immune system, newborn foals have the ability to mount robust antibody and cell-mediated immune responses to M. bovis BCG.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adaptive immunity; Foal; Horse; Mycobacterium bovis BCG; Neonatal vaccination

Mesh:

Substances:

Year:  2014        PMID: 24486362     DOI: 10.1016/j.vaccine.2014.01.032

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Antigen-specific immunoglobulin variable region sequencing measures humoral immune response to vaccination in the equine neonate.

Authors:  Rebecca L Tallmadge; Steven C Miller; Stephen A Parry; Maria Julia B Felippe
Journal:  PLoS One       Date:  2017-05-16       Impact factor: 3.240

2.  Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: Mechanism of action and validation in horse foals challenged with Rhodococcus equi.

Authors:  Colette Cywes-Bentley; Joana N Rocha; Angela I Bordin; Mariana Vinacur; Safia Rehman; Tanweer S Zaidi; Mark Meyer; Sarah Anthony; McKenzie Lambert; Daniel R Vlock; Steeve Giguère; Noah D Cohen; Gerald B Pier
Journal:  PLoS Pathog       Date:  2018-07-19       Impact factor: 6.823

3.  An Adenoviral Vector Based Vaccine for Rhodococcus equi.

Authors:  Carla Giles; Olasumbo Ndi; Mary D Barton; Thiru Vanniasinkam
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

4.  Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi.

Authors:  Joana N Rocha; Noah D Cohen; Angela I Bordin; Courtney N Brake; Steeve Giguère; Michelle C Coleman; Robert C Alaniz; Sara D Lawhon; Waithaka Mwangi; Suresh D Pillai
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

5.  Transcriptome analysis of immune genes in peripheral blood mononuclear cells of young foals and adult horses.

Authors:  Rebecca L Tallmadge; Minghui Wang; Qi Sun; Maria Julia B Felippe
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.